Episode: Recent Publications and Our Lab Inspection DebriefEpisode SummaryIn this episode, Dr. Zahner and Dr. Aakash dive into their recent article in The Pathologist, "The Vanishing Middle,"…
The Human Side of DMT: Trust, Fragility, and Why "Prove It" Kills ProgressDr. Laposata on the interpersonal realities behind diagnostic management teams — why trust matters, why clinicians engage, and…
1. The Origin Story — Why Coagulation?Coagulation became the natural birthplace of DMTs because hematology was merging with oncology in the 1980s, leaving bleeding disorders to pathology.This created…
# Why 95%? The Statistical Convention Behind Reference Intervals — and Why It Misleads Patients## Summary Chris and Dr. Aakash explain how the 95% reference interval became the standard in laboratory…
# CMS Proposes Revaluing 88305 RVUs After Maryland Claims Analysis## Summary CMS is reconsidering RVUs for pathology codes 88305 and 88307 after the Maryland Health Care Commission analyzed 2023…
# ADLM Signals, Cyclospora Surges, and CLIA Redraws the Lab## Summary Chris and Aakash break down three major signals from ADLM 2026: simultaneous centralization of high-throughput systems and…
What is Disruption in the Laboratory Defining disruption requires looking at workflow and ROI rather than just technical novelty. Summary Market disruption in the lab is not automatically signaled by…
Pre-Inspection Prep: Readiness Without PanicReadiness isn’t a binder. It’s a system.Inspection anxiety has a familiar rhythm.Suddenly policies are being printed. QC logs are double-checked. Everyone…
Episode: The Inspection Is Coming: Now What?Release Date: February 9, 2026 When inspectors are on the calendar, anxiety rises fast — but inspections aren’t really about last-minute fixes or perfect…
In this episode of LabReflex, we start with a few high-signal highlights from the past week before stepping back to ask a bigger question:Why does the future of laboratory medicine sound so different…
